Literature DB >> 2487203

Pretarsal fixation of gold weights in facial nerve palsy.

S R Seiff1, J H Sullivan, L N Freeman, J Ahn.   

Abstract

Implantation of a gold weight in the pretarsal space was performed on 17 patients with poor eyelid closure secondary to facial nerve weakness. Successful results were obtained in 14 (82%) of 17 patients. Postmortem histopathology of such a case demonstrated firm fibrous encapsulation of the weight. Although some authors advocate fixation of lid weights to the orbital septum, fixation in the pretarsal space is preferred for the following reasons: (a) "cheesewiring" is less likely to occur, (b) a limited levator recession may be more easily performed, (c) greater mechanical benefits are obtained, and (d) the potential for inferior migration is less.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2487203     DOI: 10.1097/00002341-198906000-00005

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  5 in total

1.  Surgical approaches to facial nerve deficits.

Authors:  Craig Birgfeld; Peter Neligan
Journal:  Skull Base       Date:  2011-05

2.  [Histopathology after implantation of lid weights].

Authors:  T Schrom; C Taege; G Wolf; A Reinhardt; H Scherer
Journal:  HNO       Date:  2006-08       Impact factor: 1.284

3.  Quality of Life in Patients with Unresolved Facial Nerve Palsy and Exposure Keratopathy Treated by Upper Eyelid Gold Weight Loading.

Authors:  Izabela Nowak-Gospodarowicz; Radosław Różycki; Marek Rękas
Journal:  Clin Ophthalmol       Date:  2020-08-05

4.  Low-level versus high-level placement of gold plates in the upper eyelid in patients with facial palsy.

Authors:  Tarek A Amer; Hisham M El-Minawi; Malak I El-Shazly
Journal:  Clin Ophthalmol       Date:  2011-06-30

5.  The impact of implantation site on procedure success in patients with unresolved facial palsy treated with upper-eyelid gold weight loading.

Authors:  Izabela Nowak-Gospodarowicz; Robert Koktysz; Marek Rękas
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.